Sichuan Huiyu Pharmaceutical Co Ltd (688553)

Currency in CNY
22.28
-0.32(-1.42%)
Closed·
688553 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
688553 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
21.9622.71
52 wk Range
9.7924.36
Key Statistics
Bid/Ask
22.27 / 22.28
Prev. Close
22.6
Open
22.71
Day's Range
21.96-22.71
52 wk Range
9.79-24.36
Volume
6.71M
Average Volume (3m)
12.59M
1-Year Change
89.94%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688553 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Sichuan Huiyu Pharmaceutical Co Ltd Company Profile

Sichuan Huiyu Pharmaceutical Co., Ltd. research and develops, produces, and sells anti-tumor and injection drugs in China and internationally. The company offers injection drug products, such as pemetrexed disodium, methrotraxate, docetaxel, azacitidine, oxaliplatin, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, sodium valproate concentrated solution, epirubicin hydrochloride, fulvestrant, milrinone, fluorouracil, sodium thiosulfate, zoledronic acid, zoledronic acid concentrated solution, cisatracurium besylate, bortezomib, octreotide acetate, doxorubicin, and palonosetron hydrochloride. Sichuan Huiyu Pharmaceutical Co., Ltd. was incorportaed in 2010 and is headquartered in Neijiang, China.

Employees
1382
Market
China

Compare 688553 to Peers and Sector

Metrics to compare
688553
Peers
Sector
Relationship
P/E Ratio
37.3x30.5x−0.5x
PEG Ratio
0.53−0.170.00
Price/Book
2.4x3.2x2.6x
Price / LTM Sales
8.7x4.9x3.3x
Upside (Analyst Target)
-15.0%43.4%
Fair Value Upside
Unlock4.8%7.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.60%
Dividend Yield
2.08%
Industry Median 1.51%
Annualised payout
0.46
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
239.05M / --
EPS Revisions
Last 90 days

688553 Income Statement

FAQ

What Stock Exchange Does Sichuan Huiyu Pharmaceutical Trade On?

Sichuan Huiyu Pharmaceutical is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Sichuan Huiyu Pharmaceutical?

The stock symbol for Sichuan Huiyu Pharmaceutical is "688553."

What Is the Sichuan Huiyu Pharmaceutical Market Cap?

As of today, Sichuan Huiyu Pharmaceutical market cap is 9.44B.

What Is Sichuan Huiyu Pharmaceutical's Earnings Per Share (TTM)?

The Sichuan Huiyu Pharmaceutical EPS (TTM) is 0.60.

From a Technical Analysis Perspective, Is 688553 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Sichuan Huiyu Pharmaceutical Stock Split?

Sichuan Huiyu Pharmaceutical has split 0 times.

How Many Employees Does Sichuan Huiyu Pharmaceutical Have?

Sichuan Huiyu Pharmaceutical has 1382 employees.

What is the current trading status of Sichuan Huiyu Pharmaceutical (688553)?

As of 10 Aug 2025, Sichuan Huiyu Pharmaceutical (688553) is trading at a price of 22.28, with a previous close of 22.60. The stock has fluctuated within a day range of 21.96 to 22.71, while its 52-week range spans from 9.79 to 24.36.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.